Kiora Pharmaceuticals, Inc. (KPRX) vs MetaVia Inc. (MTVA)
Kiora Pharmaceuticals, Inc. and MetaVia Inc. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. and MetaVia Inc. are of similar size ($11.8M and $10.9M). Across the 9 metrics below, Kiora Pharmaceuticals, Inc. leads on 6 and MetaVia Inc. on 3.
Valuation
Profitability
| Metric | KPRX | MTVA | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.06% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (56.36%) | (175.68%) | (57.72%) |
| Return on assets | (39.43%) | (91.06%) | (49.22%) |
| Return on invested capital | (44,053.91%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack